These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10028450)
1. The utility of ANCA and ASCA in inflammatory bowel disease. Targan SR Inflamm Bowel Dis; 1999 Feb; 5(1):61-3; discussion 66-7. PubMed ID: 10028450 [No Abstract] [Full Text] [Related]
2. [The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease]. Gisbert JP; Gomollón F; Maté J; Pajares JM Gastroenterol Hepatol; 2003 May; 26(5):312-24. PubMed ID: 12732107 [No Abstract] [Full Text] [Related]
3. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. Damoiseaux JG; Bouten B; Linders AM; Austen J; Roozendaal C; Russel MG; Forget PP; Tervaert JW J Clin Immunol; 2002 Sep; 22(5):281-8. PubMed ID: 12405161 [TBL] [Abstract][Full Text] [Related]
5. Measurement of pANCA (antineutrophil cytoplasmic antibodies) and ASCA (anti-saccharomyces cerevisiae) in screening for IBD in young children. Kugathasan S; Werlin SL Inflamm Bowel Dis; 1999 Nov; 5(4):283-4. PubMed ID: 10579122 [No Abstract] [Full Text] [Related]
8. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Rutgeerts P; Vermeire S Gastroenterology; 1998 Oct; 115(4):1006-9. PubMed ID: 9786723 [No Abstract] [Full Text] [Related]
9. The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn's disease and predicting inflammatory disease. Kaila B; Orr K; Bernstein CN Can J Gastroenterol; 2005 Dec; 19(12):717-21. PubMed ID: 16341311 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. Filik L; Biyikoglu I World J Gastroenterol; 2008 Dec; 14(47):7271. PubMed ID: 19084948 [TBL] [Abstract][Full Text] [Related]
11. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease]. Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease]. Kim JE; Kim KS; Seo JK Korean J Gastroenterol; 2003 Oct; 42(4):297-302. PubMed ID: 14634349 [TBL] [Abstract][Full Text] [Related]
13. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029 [TBL] [Abstract][Full Text] [Related]
14. [Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies: new biological tools for diagnosis of inflammatory bowel disease]. Bourreille A; Doubremelle M; Colombel JF Rev Med Interne; 2003 Mar; 24(3):147-50. PubMed ID: 12657435 [No Abstract] [Full Text] [Related]